Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Oncoimmunology|September 22, 2017
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancerDagmar Kollmann, Thomas Schweiger, Stefan Schwarz, et al.
Cells|November 2, 2019
The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal CancerElisabeth S Gruber, Georg Oberhuber, Peter Birner, et al.
Cancers|August 28, 2025
Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic StratificationGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2006
Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinomaThomas Bachleitner-Hofmann, Michaela Strohschneider, Peter Krieger, et al.
Cancer|April 29, 2014
Mutant IDH1 inhibits PI3K/Akt signaling in human gliomaPeter Birner, Stefan Pusch, Christo Christov, et al.
Cells|December 29, 2020
Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. <i>Cells</i> 2019, <i>8</i>, 1357Elisabeth S Gruber, Georg Oberhuber, Peter Birner, et al.
Obesity Surgery|January 18, 2022
Trends of Overweight and Obesity in Male Adolescents: Prevalence, Socioeconomic Status, and Impact on Cardiovascular Risk in a Central European CountryLisa Gensthaler, Daniel M Felsenreich, Julia Jedamzik, et al.
Pathology Oncology Research : POR|May 7, 2020
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control StudyAndrea Beer, Hossein Taghizadeh, Ana-Iris Schiefer, et al.
Annals of Surgery|July 27, 2004
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancerSebastian F Schoppmann, Guenther Bayer, Klaus Aumayr, et al.
Anticancer Research|July 31, 2013
Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tractAysegül Ilhan-Mutlu, Matthias Preusser, Sebastian F Schoppmann, et al.
Pageof 17